The largest database of trusted experimental protocols

Il 8 antibody

Manufactured by Abcam
Sourced in United Kingdom, United States

The IL-8 antibody is a reagent used in various research and laboratory applications. It is designed to detect and bind to the interleukin-8 (IL-8) protein, which is a cytokine involved in the immune response and inflammation. The antibody can be used in techniques such as Western blotting, ELISA, and immunohistochemistry to study the expression and localization of IL-8 in different biological samples.

Automatically generated - may contain errors

5 protocols using il 8 antibody

1

In vitro Scratch Wound Healing Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PIEC migration was determined as previously described [29 (link)] with minor modifications. PIECs were seeded (4×105cells/well) into 6-well plates and cultured for 24 h under static conditions. The confluent EC monolayer was scraped in a straight line with a 200 μL pipette tip to create a wound parallel to the direction of the flow. Wounded monolayers were washed once with 1 mL of growth medium to remove cell debris. The in vitro scratch wound healing assay was performed under four different conditions including a control group, PCV2-infected group, IL-8-antibody group, and PCV2-infected-IL-8-antibody group (n = 3 wells per group). PCV2-infected groups were infected as described above. IL-8 antibody was added into the cell supernatants at a final concentration of 3 µg/mL (Abcam, Cambridge, UK) to the relevant groups. The cells were grown in a humidified 5% CO2 atmosphere at 37°C for 24 h. Images of the cell monolayer around the wounds were taken with an Olympus inverted phase microscope at 24 hpi (Olympus, Tokyo, Japan).
Data were presented as wound closure (%): Wound closure [(A0 -At)/A0]×100% where A0 is the area of the original wound and At is the area of wound measured 24 hpi. All experiments were repeated at least three times.
+ Open protocol
+ Expand
2

Optimizing Inhibitor Concentration for DC-PIEC Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To screen the optimal concentration of inhibitors, the induced DCs were cultured in complete medium with 2 μM, 5 μM, 10 μM, or 20 μM of BAY 11-7082 (Beyotime, Shanghai, China) or Ruxolitinib (Selleck Chemicals, Houston, TX, USA). After 1 h of incubation, the culture medium was discarded, washed three times, and then 10% RPMI1640 induction medium was added to the upper chamber of the transwell membranes for a further 48 h. These MoDCs were collected to detect IL-12 mRNA and determine their optimal concentration. DCs treated at the optimal concentration were co-cultured with PIECs of different treatments. To minimize the impact of other factors, we established an IL-8 antibody panel by adding IL-8 antibody (Abcam, Cambridge, MA, USA) at a final concentration of 5 μg/mL to the co-culture. The six groups in the NF-κB signaling pathway experiment included PCV2-PIECs-DCs, IL-8Ab-PCV2-PIECs-DCs, IL-8Ab-PCV2-PIECs-BAY-DCs, IL-8over-PIECs-DCs, Ab-IL-8over-PIECs-DCs, and Ab-IL-8over-PIECs-BAY-DCs. The six groups in the JAK-STAT signaling pathway experiment included PCV2-PIECs-DCs, IL-8Ab-PCV2-PIECs-DCs, IL-8Ab-PCV2-PIECs-RUX-DCs, IL-8over-PIECs-DCs, Ab-IL-8over-PIECs-DCs, and Ab-IL-8over-PIECs-RUX-DCs. The DCs of different groups were used for flow cytometry and quantitative real-time PCR.
+ Open protocol
+ Expand
3

Immunofluorescence Analysis of IL-8 in Mox-LDL-Treated HAECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HAECs that were either treated with Mox-LDL (100 µg/mL) or left untreated, were seeded onto coverslips and fixed with 4% PFA at 4 ºC. Cells were washed with PBS (1X) 3 times. Then, they were blocked for 1 h with PBS (1X) and 3% normal goat serum (NGS) and incubated again for 3 h with interleukin-8 (IL-8) antibody (abcam, USA) prepared in PBS (1X) and 1% NGS. Cells were further incubated with Alexa fluor 488 secondary antibodies (Invitrogen, USA) prepared in PBS (1X) and 1% NGS for 1 h. Nuclei were counterstained with Hoechst 33,324 (Thermo Fisher, Molecular Probes, Eugene, OR, USA). Coverslips were mounted onto glass slides using Prolong Antifade (Molecular Probes) and slides were observed under the LSM 710 microscope at 40× magnification.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of IL-8 in Schizophrenia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brain tissues of schizophrenia patients and normal controls were first embedded in paraffin, cut into 5 µm sections and heated at 70°C in the oven for 6 hours. Sections were dewaxed in xylene and brought to water through graded alcohols. IL-8 antibody (1:500; Abcam, Cambridge, UK) and secondary antibody (1:5,000; Abcam) were then added. Sections were rinsed three times with PBS, incubated with 3,3′-diaminobenzidine, stained with hematoxylin and finally fixed with neutral balata.
+ Open protocol
+ Expand
5

Western Blot Analysis of Macrophage Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The macrophages were collected and lysed with RIPA buffer (Solarbio, China). Protein concentration was quantified using a Bio-Rad protein assay kit (Bio-Rad). Protein samples were separated by 12% SDS-PAGE. Then electrophoretically transferred onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad). The membranes were incubated in primary antibodies (β-actin (Proteintech, China); IL-6 antibody; MCP-1 antibody; MMP-9 antibody, dilution 1:1,000 (CST, Germany); and IL-8 antibody, dilution 1:1,000 (Abcam, USA)) at 4°C overnight. Then membranes were incubated with horseradish peroxidase-coupled secondary antibody (antirabbit or antimouse antibodies, dilution 1:2,000 (Proteintech, China)) for 1 h at room temperature (Santa Cruz Biotechnology). The signals were detected by the chemiluminescence detection kit (Thermo Fisher Scientific). The protein bands were visualized by autoradiography and quantified by ImageJ software (National Institutes of Health, Bethesda, MD, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!